Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants

Early Hum Dev. 2012 Mar:88 Suppl 1:S3-4. doi: 10.1016/j.earlhumdev.2011.12.019. Epub 2012 Jan 21.

Abstract

The INSURE method, which consists of an intubation-surfactant-extubation sequence, is effective in reducing the need for mechanical ventilation (MV), the duration of respiratory support, and the need for surfactant replacement in preterm infants with respiratory distress syndrome. Although beneficial, the INSURE method fails to avoid MV in selected patients. We demonstrated that body weight <750 g, pO(2)/FiO(2) <218, and a/ApO(2) <0.44 at the first blood gas analysis are independent risk factors for INSURE failure in infants with gestational age <30 weeks. Moreover, we demonstrated that the INSURE treatment can be safely repeated with the aim to avoid MV, since the respiratory outcome did not differ between infants treated with single or multiple INSURE procedures.

MeSH terms

  • Airway Extubation / methods*
  • Blood Gas Analysis
  • Body Weight / physiology*
  • Cohort Studies
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Intubation / methods*
  • Oxygen / blood*
  • Pulmonary Surfactants / administration & dosage
  • Pulmonary Surfactants / therapeutic use*
  • Regression Analysis
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Respiratory Distress Syndrome, Newborn / therapy*
  • Risk Factors
  • Sensitivity and Specificity
  • Treatment Failure

Substances

  • Pulmonary Surfactants
  • Oxygen